Team-based primary care reforms and older adults: a descriptive assessment of sociodemographic trends and prescribing endpoints in two Canadian provinces.
Canada
Medication management
Older adults
Polypharmacy
Primary care
Team-based care
Journal
BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676
Informations de publication
Date de publication:
10 01 2023
10 01 2023
Historique:
received:
19
07
2022
accepted:
27
12
2022
entrez:
10
1
2023
pubmed:
11
1
2023
medline:
13
1
2023
Statut:
epublish
Résumé
Team-based primary care reforms aim to improve care coordination by involving multiple interdisciplinary health professionals in patient care. Team-based primary care may support improved medication management for older adults with polypharmacy and multiple points of contact with the healthcare system. However, little is known about this association. This study compares sociodemographic and prescribing trends among older adults in team-based vs. traditional primary care models in Ontario and Quebec. We constructed two provincial cohorts using population-level health administrative data from 2006-2018. Our primary exposure was enrollment in a team-based model of care. Key endpoints included adverse drug events (ADEs), potentially inappropriate prescriptions (PIPs), and polypharmacy. We plotted prescribing trends across the observation period (stratified by model of care) in each province. We used standardized mean differences to compare characteristics of older adults and providers, as well as prescribing endpoints. Formal patient/physician enrollment increased in both provinces since the time of policy implementation; team-based enrollment among older adults was higher in Quebec (47%) than Ontario (33%) by the end of our observation period. The distribution of sociodemographic characteristics was reasonably comparable between team-based and non-team-based patients in both provinces, aside from a persistently higher share of rural patients in team-based care. Most PIPs assessed either declined or remained relatively steady over time, regardless of model of care and province. Several PIPs were more common among team-based patients than non-team-based patients, particularly in Quebec. We did not detect notable trends in ADEs or polypharmacy in either province. Our findings offer encouraging evidence that many PIPs are declining over time in this population, regardless of patients' enrollment in team-based care. Rates of decline appear similar across models of care, suggesting these models may not meaningfully influence prescribing endpoints. Additional efforts are needed to understand the impact of team-based care among older adults and improve primary care prescribing practices.
Sections du résumé
BACKGROUND
Team-based primary care reforms aim to improve care coordination by involving multiple interdisciplinary health professionals in patient care. Team-based primary care may support improved medication management for older adults with polypharmacy and multiple points of contact with the healthcare system. However, little is known about this association. This study compares sociodemographic and prescribing trends among older adults in team-based vs. traditional primary care models in Ontario and Quebec.
METHODS
We constructed two provincial cohorts using population-level health administrative data from 2006-2018. Our primary exposure was enrollment in a team-based model of care. Key endpoints included adverse drug events (ADEs), potentially inappropriate prescriptions (PIPs), and polypharmacy. We plotted prescribing trends across the observation period (stratified by model of care) in each province. We used standardized mean differences to compare characteristics of older adults and providers, as well as prescribing endpoints.
RESULTS
Formal patient/physician enrollment increased in both provinces since the time of policy implementation; team-based enrollment among older adults was higher in Quebec (47%) than Ontario (33%) by the end of our observation period. The distribution of sociodemographic characteristics was reasonably comparable between team-based and non-team-based patients in both provinces, aside from a persistently higher share of rural patients in team-based care. Most PIPs assessed either declined or remained relatively steady over time, regardless of model of care and province. Several PIPs were more common among team-based patients than non-team-based patients, particularly in Quebec. We did not detect notable trends in ADEs or polypharmacy in either province.
CONCLUSIONS
Our findings offer encouraging evidence that many PIPs are declining over time in this population, regardless of patients' enrollment in team-based care. Rates of decline appear similar across models of care, suggesting these models may not meaningfully influence prescribing endpoints. Additional efforts are needed to understand the impact of team-based care among older adults and improve primary care prescribing practices.
Identifiants
pubmed: 36627566
doi: 10.1186/s12875-022-01960-z
pii: 10.1186/s12875-022-01960-z
pmc: PMC9832790
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7Subventions
Organisme : CIHR
ID : PJT156326
Pays : Canada
Informations de copyright
© 2023. The Author(s).
Références
CMAJ Open. 2016 Jun 22;4(2):E346-51
pubmed: 27398383
Health Policy. 2019 Feb;123(2):215-221
pubmed: 30583803
JMIR Res Protoc. 2016 Jun 24;5(2):e126
pubmed: 27341765
J Prim Care Community Health. 2019 Jan-Dec;10:2150132719890227
pubmed: 31808725
Health Policy. 2014 Jun;116(2-3):264-72
pubmed: 24602377
J Am Geriatr Soc. 2019 Apr;67(4):674-694
pubmed: 30693946
Ann Fam Med. 2011 Mar-Apr;9(2):165-71
pubmed: 21403144
Br J Clin Pharmacol. 2021 Nov;87(11):4150-4172
pubmed: 34008195
Int J Clin Pharmacol Ther. 2008 Feb;46(2):72-83
pubmed: 18218287
Health Policy. 2021 Sep;125(9):1121-1130
pubmed: 34176672
J Gerontol A Biol Sci Med Sci. 2014 Jun;69(6):640-9
pubmed: 24249734
Health Serv Res. 2017 Aug;52(4):1550-1569
pubmed: 27678072
Can Geriatr J. 2018 Sep 30;21(3):269-273
pubmed: 30271512
CMAJ. 1994 Jun 1;150(11):1801-9
pubmed: 8199957
Health Policy. 2020 Jul;124(7):743-750
pubmed: 32507524
CMAJ. 2008 Jun 3;178(12):1563-9
pubmed: 18519904
Milbank Q. 2005;83(3):457-502
pubmed: 16202000
J Health Econ. 2017 Sep;55:76-94
pubmed: 28728807
Lancet Healthy Longev. 2021 May;2(5):e290-e300
pubmed: 36098136
Can J Aging. 2017 Mar;36(1):97-107
pubmed: 28091333
BMC Clin Pharmacol. 2007 Sep 25;7:9
pubmed: 17894876
JAMA. 1998 Apr 15;279(15):1200-5
pubmed: 9555760
Am J Geriatr Pharmacother. 2007 Mar;5(1):31-9
pubmed: 17608245
Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):322-333
pubmed: 34748234
CMAJ. 2017 Jan 9;189(1):E42-E43
pubmed: 27873758
CMAJ. 2009 May 26;180(11):1091-2
pubmed: 19468110
J Pharm Pract. 2016 Apr;29(2):132-7
pubmed: 25312264
Age Ageing. 2016 Jul;45(4):535-42
pubmed: 27151390
Drug Saf. 2012 Sep 1;35(9):769-81
pubmed: 22823502